TDAG51 inhibitors belong to a distinctive class of chemical compounds designed to influence the activity of TDAG51, also known as T-cell death-associated gene 51. TDAG51 is a protein encoded by the TDAG51 gene, found in various tissues and cell types throughout the human body. This protein plays a pivotal role in multiple cellular processes, primarily associated with cell survival, apoptosis (programmed cell death), and cell differentiation. The development of TDAG51 inhibitors stems from the recognition of TDAG51's involvement in diverse physiological and pathological processes, making it an intriguing target for research and applications beyond traditional drug development.
TDAG51 inhibitors operate by disrupting the normal function of the TDAG51 protein. These compounds can either bind to TDAG51 directly or affect its downstream signaling pathways, ultimately influencing cellular responses associated with TDAG51. By inhibiting TDAG51, these compounds may have the ability to regulate cell fate decisions, including cell survival and death, which could hold significant implications in various biological contexts. The study of TDAG51 inhibitors is an engrossing area of research, as it not only deepens our understanding of cellular processes but also broadens the scope of applications in the future, though their specific applications are still a subject of ongoing investigation and scientific exploration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
O-1918 | 536697-79-7 | sc-202746 sc-202746A | 1 mg 5 mg | $61.00 $235.00 | ||
O-1918 is a synthetic compound that acts as a TDAG51 inhibitor. It functions as an antagonist of the GPR55 receptor, which is linked to TDAG51 activation. By blocking GPR55, O-1918 indirectly inhibits TDAG51-mediated cellular responses and inflammation. | ||||||
CID 2745687 | 264233-05-8 | sc-362725 sc-362725A | 10 mg 50 mg | $200.00 $800.00 | 1 | |
CID-2745687 is a small molecule inhibitor of TDAG51. Its mechanism of action involves disrupting TDAG51 signaling pathways, leading to a reduction in intracellular calcium levels and inhibition of TDAG51-mediated cellular responses. | ||||||
(±)-Cannabichromene | 20675-51-8 | sc-504602 | 1 mg | $159.00 | ||
CBC, a natural cannabinoid, indirectly inhibits TDAG51 through CB2 receptor activation. It lowers intracellular calcium levels and suppresses TDAG51-mediated inflammatory and apoptotic actions in various cell types. | ||||||